Notice Type
Departmental
Notice Title

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Pulmozyme
Active Ingredient: Dornase alfa 1mg/mL
Dosage Form: Solution for inhalation
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturers: Automatic Liquid Packaging Inc, Woodstock, Illinois, United States of America
Genentech Inc, South San Francisco, California, United States of America
Product: Synagis
Active Ingredient: Palivizumab 100mg
Dosage Form: Powder for injection
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturers: Abbott Laboratories SpA, Campoverde di Aprilia, Latina, Italy
Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
Product: Synagis
Active Ingredient: Palivizumab 50mg
Dosage Form: Powder for injection
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturers: Abbott Laboratories SpA, Campoverde di Aprilia, Latina, Italy
Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
Product: Zyprexa Zydis
Active Ingredient: Olanzapine 10mg
Dosage Form: Wafer
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: Scherer DDS Limited, Blagrove, Swindon, Wiltshire, England
Product: Zyprexa Zydis
Active Ingredient: Olanzapine 15mg
Dosage Form: Wafer
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: Scherer DDS Limited, Blagrove, Swindon, Wiltshire, England
Product: Zyprexa Zydis
Active Ingredient: Olanzapine 20mg
Dosage Form: Wafer
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: Scherer DDS Limited, Blagrove, Swindon, Wiltshire, England
Product: Zyprexa Zydis
Active Ingredient: Olanzapine 5mg
Dosage Form: Wafer
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: Scherer DDS Limited, Blagrove, Swindon, Wiltshire, England
Product: Zyprexa
Active Ingredient: Olanzapine 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers: Eli Lilly and Company Limited, Kingsclere Road, Basingstoke, Hampshire, England
Lilly del Caribe, Inc., Carolina, Puerto Rico
Product: Zyprexa
Active Ingredient: Olanzapine 2.5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers: Eli Lilly and Company Limited, Basingstoke, Hampshire, England
Lilly del Caribe, Inc., Carolina, Puerto Rico
Product: Zyprexa
Active Ingredient: Olanzapine 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers: Eli Lilly and Company Limited, Basingstoke, Hampshire, England
Lilly del Caribe, Inc., Carolina, Puerto Rico
Product: Zyprexa
Active Ingredient: Olanzapine 7.5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers: Eli Lilly and Company Limited, Basingstoke, Hampshire, England
Lilly del Caribe, Inc., Carolina, Puerto Rico
Dated this 24th day of November 2003.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the
6th day of July 2001).